Mitoquinone mesylate

Mitoquinone mesylate (also known as MitoQ) is a mitochondria-targeted antioxidant that has been developed to protect against oxidative stress. It is a derivative of Coenzyme Q10 (CoQ10) and has been shown to be more effective than CoQ10 in reducing oxidative damage and improving mitochondrial function.

Chemistry

Mitoquinone mesylate is a quinone compound that is structurally similar to CoQ10, but with a triphenylphosphonium (TPP) cation attached. This modification allows MitoQ to accumulate in the mitochondria, where it can exert its antioxidant effects more effectively than CoQ10.

Mechanism of action

MitoQ works by reducing oxidative stress in the mitochondria. It does this by acting as an electron carrier in the electron transport chain, helping to maintain a normal mitochondrial membrane potential and prevent the formation of reactive oxygen species (ROS). By reducing the levels of ROS, MitoQ can help to protect cells from oxidative damage and improve mitochondrial function.

Clinical applications

MitoQ has been investigated for its potential use in a number of medical conditions, including Parkinson's disease, Alzheimer's disease, cardiovascular disease, and liver disease. It has also been studied for its potential to improve ageing and longevity.

Safety and side effects

MitoQ is generally well tolerated, with few reported side effects. However, as with any supplement, it should be used under the supervision of a healthcare provider.

See also

• Coenzyme Q10
• Mitochondria
• Oxidative stress
• Antioxidant

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

•